Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA.
Saved in:
| Title: | Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA. |
|---|---|
| Authors: | Albers, Frank C.1,2 frank-c.albers@t-online.de, Papi, Alberto3, Taillé, Camille4, Bratton, Daniel J.5, Bradford, Eric S.6, Yancey, Steven W.6, Kwon, Namhee7 |
| Source: | Respiratory Research. 7/30/2019, Vol. 20 Issue 1, pN.PAG-N.PAG. 1p. 7 Diagrams, 1 Chart. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14659921 |
|---|---|
| DOI: | 10.1186/s12931-019-1134-7 |
